商标名 | 通用名称 | 中文名称 | ATC编码 | 授权日期 | 上市许可持有人 | 市场状态 |
---|---|---|---|---|---|---|
查看 | nitisinone | 尼替西农 | A16AX04 | 2018-07-26 | Cycle Pharmaceuticals (Europe) Ltd | Authorised |
查看 | tabelecleucel | 他贝来塞 | 2022-12-16 | Pierre Fabre Medicament | Authorised | |
查看 | casirivimab, imdevimab | 卡斯瑞韦单抗;依米得韦单抗 | J06BD | 2021-11-12 | Roche Registration GmbH | Authorised |
查看 | secukinumab | 司库奇尤单抗 | L04AC10 | 2015-01-14 | Novartis Europharm Limited | Authorised |
查看 | vandetanib | 凡他尼布 | L01XE | 2012-02-16 | Genzyme Europe BV | Authorised |
查看 | adalimumab | 阿达木单抗 | L04AB04 | 2021-11-15 | Stada Arzneimittel AG | Authorised |
查看 | leflunomide | 来氟米特 | L04AA13 | 2010-07-27 | medac Gesellschaft für klinische Spezialpräparate mbH | Authorised |
查看 | melatonin | 美乐托宁 | N05CH01 | 2007-06-29 | RAD Neurim Pharmaceuticals EEC SARL | Authorised |
查看 | phenylephrine, ketorolac | 酮咯酸;去氧肾上腺素 | S01 | 2015-07-28 | Rayner Surgical (Ireland) Limited | Authorised |
查看 | olanzapine | 奥氮平 | N05AH03 | 2010-06-10 | Apotex Europe BV | Authorised |
查看 | naldemedine | 甲苯磺酸纳地美定 | A06AH05 | 2019-02-18 | Shionogi B.V. | Authorised |
查看 | rivaroxaban | 利伐沙班 | B01AF01 | 2021-11-12 | Mylan Ireland Limited | Authorised |
查看 | leflunomide | 来氟米特 | L04AA13 | 1999-09-02 | Sanofi-aventis Deutschland GmbH | Authorised |
查看 | lacosamide | 拉科酰胺 | N03AX18 | 2008-08-29 | UCB Pharma SA | Authorised |
查看 | regorafenib | 瑞戈非尼 | L01EX05 | 2013-08-26 | Bayer Pharma AG | Authorised |
查看 | brivaracetam | 布瓦西坦 | N03AX23 | 2016-01-13 | UCB Pharma SA | Authorised |
查看 | human fibrinogen, human thrombin | 人纤维蛋白原;人凝血酶 | B02BC | 2008-10-05 | Omrix Biopharmaceuticals N. V. | Authorised |
查看 | letermovir | 来特莫韦 | J05 | 2018-01-08 | Merck Sharp & Dohme B.V. | Authorised |
查看 | abiraterone acetate | 醋酸阿比特龙 | L02BX03 | 2021-06-24 | Krka, d.d., Novo mesto | Authorised |
查看 | cefiderocol | 头孢德罗 | J01D | 2020-04-23 | Shionogi B.V. | Authorised |